Document is current

Article History

Accepted: 28 February 2021

First Online: 24 March 2021

Declarations

:

: The following postgraduate scholarships support Ann Livingstone: Australian National Health and Medical Research Council (NHMRC) APP1168194, Sydney Catalyst and Melanoma Institute Australia (MIA). The Australian NHMRC Centre of Research Excellence in Melanoma grant APP1135285 supports Kathy Dempsey. A Western Sydney Local Health District Fellowship supports Danielle Marie Muscat. A Cancer Institute New South Wales Fellowship and the MIA support Alexander M. Menzies. An Australian NHMRC Investigator Grant, APP1194703 and a University of Sydney Robinson Fellowship support Rachael L. Morton.

: Ann Livingstone, Kathy Dempsey, Danielle Marie Muscat, Kirsten Howard and Rachael L. Morton have no conflicts of interest that are directly relevant to the content of this article. Donna Milne served on advisory boards for BMS, MSD and Novartis, and received BMS and Merck competitive research funding. Martin R. Stockler received institutional research support from Amgen, Astellas, AstraZeneca, Bayer, Bionomics, BMS, Celgene, Medivation, MSD, Pfizer, Roche, Sanofi and Tilray, but does not sit on any advisory boards. Alexander M. Menzies served on advisory boards for BMS, MSD, Novartis, Roche, Pierre-Fabre and Qbiotics.

: The Sydney Local Health District Human Research Ethics Committee (HREC/18/RPAH/736) granted ethics approval. The Declaration of Helsinki underpinned this study.

: All participants provided written consent to participate in this study.

: De-identified datasets used and analysed during the current study may be available from the corresponding author if the request falls within the project’s ethics approval.

: AL: Conceptualisation, methodology, resources, writing/original draft preparation; DM and AMM: supervision, assistance with participant recruitment, writing, critical review/editing; KD: qualitative coding and analysis, writing, critical review/editing; DMM: assistance with focus groups, writing, critical review/editing; MRS and KH: supervision, writing, critical review/editing; RLM: conceptualisation, supervision, assistance with focus groups, resources, writing, critical review/editing.

: All authors have reviewed and approved the manuscript and consented to its publication.

: The code used for analyses can be made available upon request for non-commercial use.